文献速递妇产影像泌尿生殖技术与安全PETCT

妇科与泌尿生殖系统肿瘤影像中FDG PET/CT的陷阱

FDG PET/CT Pitfalls in Gynecologic and Genitourinary Oncologic Imaging.
PubMed 文献 · Radiographics · 2017-01-01

全文阐述FDG PET/CT在妇科与泌尿生殖系统恶性肿瘤评估中的已确立作用,系统归类可导致假阳性或假阴性的常见陷阱,包括生理性摄取、良性病变摄取、低代谢肿瘤及技术限制,并强调掌握生理与非生理性摄取特征及患者准备与扫描方案原则对准确判读的重要性。

要点

  • 绝经前妇女子宫内膜和卵巢的生理性FDG摄取可被误判为病变。
  • 坏死性、黏液性、囊性或低级别肿瘤FDG摄取低,易致假阴性。
  • 呼吸运动和肠蠕动伪影及PET空间分辨率有限可限制小体积病灶评估。

核心结论

  • FDG PET/CT广泛用于妇科与泌尿生殖系统肿瘤的分期、复发评估和预后判断,但存在可致假阳性或假阴性的多种陷阱,掌握关键影像特征与扫描方案原则对准确判读很重要。

研究设计与样本

  • 本文为综述,总结FDG PET/CT在妇科与泌尿生殖系统肿瘤影像中的陷阱,未报告检索范围与纳入文献数量。

关键影像表现/征象

  • 潜在假阳性包括绝经前患者子宫内膜和卵巢的生理性FDG摄取、肾脏生理性排泄FDG至输尿管和膀胱,以及子宫肌瘤、盆腔炎性疾病和良性子宫内膜异位囊肿等良性病变的FDG活性增高。
  • 潜在假阴性包括坏死性、黏液性、囊性或低级别肿瘤的低水平FDG摄取,以及邻近生理性肠管或膀胱活性掩盖浆膜和腹膜病变。
  • 固有技术限制如呼吸运动和肠蠕动所致运动伪影及PET有限的空间分辨率,可能限制小体积恶性病变的评估。

临床应用与阅片要点

  • 了解生理性与非生理性FDG摄取的关键影像特征,并理解充分患者准备和PET扫描方案的原则,对准确判读妇科与泌尿生殖系统肿瘤FDG PET/CT研究很重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The role of whole-body positron emission tomography (PET)/computed tomography (CT) with fluorodeoxyglucose ( FDG fluorodeoxyglucose ) is now established in the assessment of many gynecologic and genitourinary malignant tumors. FDG fluorodeoxyglucose PET/CT has been widely adopted for staging assessments in patients with suspected advanced disease, in cases of suspected disease recurrence, and for determining prognosis in a number of malignancies. A number of pitfalls are commonly encountered when reviewing FDG fluorodeoxyglucose PET/CT scans in gynecologic and genitourinary cases; these pitfalls can be classified into those that yield potential false-positive or false-negative results. Potential false positives include physiologic uptake of FDG fluorodeoxyglucose by the endometrium and ovaries in premenopausal patients, physiologic renal excretion of FDG fluorodeoxyglucose into the ureters and the urinary bladder, and increased FDG fluorodeoxyglucose activity in benign conditions such as uterine fibroids, pelvic inflammatory disease, and benign endometriotic cysts. Potential false negatives include low-level FDG fluorodeoxyglucose uptake by necrotic, mucinous, cystic, or low-grade tumors and the masking of serosal and peritoneal disease by adjacent physiologic bowel or bladder activity. In addition, there are inherent technical limitations-such as motion artifact (from respiratory motion and bowel peristalsis) and the limited spatial resolution of PET-that may limit the assessment of small-volume malignant disease. Knowledge of the key imaging features of physiologic and nonphysiologic FDG fluorodeoxyglucose uptake, in addition to understanding the principles of adequate patient preparation and PET scanning protocols, is important for accurate interpretation of gynecologic and genitourinary oncologic FDG fluorodeoxyglucose PET/CT studies. ©RSNA, 2017.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Lakhani A, Khan SR, Bharwani N, et al. FDG PET/CT Pitfalls in Gynecologic and Genitourinary Oncologic Imaging. Radiographics. 2017. PMID: 28287942. doi:10.1148/rg.2017160059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。